On ECHEMI
Home > Drugs > Yaopharma Co., Ltd.
Yaopharma Co., Ltd.
  • Founded in:

    1997-07-21
  • Country:

    China China
  • Address:

    No. 100, Xingguang Avenue, Renhe Town, Yubei District, Chongqing
  • Tax NO.:

    91500000202851807X
  • Registered Funds:

    196.54 million yuan
  • Website:

  • Email:

Related Drugs
Calcium folinate injection
The main ingredient of this product is calcium folinate. Its chemical name is N-[4-[(2-amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl-L-glutamic acid calcium salt pentahydrate. Its structural formula is: molecular formula: C20H21CaN7O75H2O, molecular weight: 601.61.
Name Description Content CAS NO. Registered Holders
Calcium folinatc

This product is a formyl derivative of tetrahydrofolate, mainly used for the rescue of high-dose methotrexate and other folic acid antagonists. It is converted into tetrahydrofolate by tetrahydrofolate reductase, which can effectively counteract the toxic reaction caused by methotrexate, but has no obvious effect on the existing methotrexate neurotoxicity.

More

This product is a formyl derivative of tetrahydrofolate, mainly used for the rescue of high-dose methotrexate and other folic acid antagonists. It is converted into tetrahydrofolate by tetrahydrofolate reductase, which can effectively counteract the toxic reaction caused by methotrexate, but has no obvious effect on the existing methotrexate neurotoxicity.

6035-45-6 6
Reduced Glutathione for Injection
The main ingredients and chemical names of this product are: Reduced Glutathione
Name Description Content CAS NO. Registered Holders
Glutathione

Activates multiple enzymes (such as sulfhydryl (-SH) enzymes, etc.), promotes the metabolism of sugar, fat and protein; accelerates its excretion by combining sulfhydryl groups with free radicals, reduces the toxic side effects of chemotherapy and radiotherapy; protects the renal tubules from damage by cisplatin; has obvious effects in treating radiation enteritis; reduces tissue damage caused by anemia, poisoning or tissue inflammation and promotes repair; protects liver function, promotes bile acid metabolism, and facilitates the absorption of fat and fat-soluble vitamins (A, D, E, K) in the digestive tract.

More

Activates multiple enzymes (such as sulfhydryl (-SH) enzymes, etc.), promotes the metabolism of sugar, fat and protein; accelerates its excretion by combining sulfhydryl groups with free radicals, reduces the toxic side effects of chemotherapy and radiotherapy; protects the renal tubules from damage by cisplatin; has obvious effects in treating radiation enteritis; reduces tissue damage caused by anemia, poisoning or tissue inflammation and promotes repair; protects liver function, promotes bile acid metabolism, and facilitates the absorption of fat and fat-soluble vitamins (A, D, E, K) in the digestive tract.

70-18-8 11
Lysine aspirin
Name Description Content CAS NO. Registered Holders
DL-Lysine acetylsalicylate

Extract from the above information

More

Extract from the above information

62952-06-1 13
Lipoic Acid
Name Description Content CAS NO. Registered Holders
Lipoic acid

Unspecified

More

Unspecified

62-46-4 18
Alfacalcidol Tablets
The main ingredient is alfacalcidol.
Name Description Content CAS NO. Registered Holders
Alfacalcidol

After being rapidly converted into 1alpha;, 25-dihydroxyvitamin VtD3 by the liver, it regulates the balance of calcium and phosphorus in the body, increases intestinal absorption of calcium and phosphorus, promotes bone mineralization, reduces plasma parathyroid hormone levels, reduces bone calcium elimination, relieves bone and muscle pain, and improves intestinal calcium malabsorption associated with osteoporosis caused by menopause, aging, and the use of glucocorticoids.

More

After being rapidly converted into 1alpha;, 25-dihydroxyvitamin VtD3 by the liver, it regulates the balance of calcium and phosphorus in the body, increases intestinal absorption of calcium and phosphorus, promotes bone mineralization, reduces plasma parathyroid hormone levels, reduces bone calcium elimination, relieves bone and muscle pain, and improves intestinal calcium malabsorption associated with osteoporosis caused by menopause, aging, and the use of glucocorticoids.

41294-56-8 17
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.